RE:RE:RE:Let's listen in on the webinarConcur. And not to "whine", the ENWAVE management team seems stuck in a box (looking inwards too much).
Long time investors have not seen share holder delight yet. AND like I said in my previous post, "tough to hold" here.
To be more precise, the royalties are consumed by a precious few. I don't understand nor appreciate that. Surely, innovation and respective reward/recognition is better coupled with a wider set of contributors (e.g., employee bonus, base pay -- or dividends to share holders).
Finally, need to be more transparent on "engineering" costs? Why so high? has there been any new patent(s) or increase in their country of coverage? Otherwise, what (software and hardware) innovations going on with REV? To me that technology was developed and proven several years ago -- so the biggest cost should be finding new customers... correct?
PS ... Maybe the board needs to shrink in size (too). REV technology is game-changer -- but yet it seems its success has only been enjoyed in fruit/snack/diary worlds. What in earth has gone wrong with "hemp" and "medical" efforts -- where are the machine sales to those business sectors?